Table 5.
Cn (mL/mmHg) | p-Value | ||
---|---|---|---|
Dapagliflozin Group | Control Group | ||
Pre-intervention | 4.82 ± 1.71 | 5.21 ± 1.99 | 0.546 |
Post-intervention | 5.73 ± 2.19 | 4.68 ± 1.73 | 0.121 |
p-value (post-pre) | 0.017 | 0.379 | |
Delta (Δ) | 0.90 ± 1.29 | −0.53 ± 2.57 | 0.049 |
Cn (mL/mmHg) | p-Value | ||
---|---|---|---|
Dapagliflozin Group | Control Group | ||
Pre-intervention | 4.82 ± 1.71 | 5.21 ± 1.99 | 0.546 |
Post-intervention | 5.73 ± 2.19 | 4.68 ± 1.73 | 0.121 |
p-value (post-pre) | 0.017 | 0.379 | |
Delta (Δ) | 0.90 ± 1.29 | −0.53 ± 2.57 | 0.049 |